RUN vs TMO · P/E 6.0, rev $2.04B vs P/E 24, rev $44.56B
Sunrun Inc (RUN) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the RUN and TMO stock pages for the full models.
Not investment advice.